5 Lupus Nephritis Clinical Trials in Miami, FL (2026)

Q: How do I join a clinical trial in Miami?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Miami research site will contact you.

Recruiting Lupus Nephritis Studies in Miami

NCT06751043Recruiting

Preoperative Fasting vs. Not Fasting in Critically Ill Patients

The goal of this clinical trial is to learn if fasting or not fasting before a procedure has an effect on recovery in those who are critically ill. The main questions it aims to answer for patients on...

Miami, FLNA1,072 participantsMassachusetts General Hospital

View Study Details

NCT05367245Recruiting

Ca-Mg Butyrate in GWI

The primary objective of this clinical trial is to determine if treatment with Butyrate formulation that consists of butyric acid as calcium and magnesium derivatives (Ca-Mg Butyrate) improves the phy...

Miami, FLPHASE2120 participantsVA Office of Research and Development

View Study Details

NCT06557265Recruiting

A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)

This is a Phase 1/2, open-label, multi-center, multi-cohort, non-randomized dose escalation and dose expansion basket study to determine the safety and tolerability of NKX019 (allogeneic CAR NK cells ...

Miami, FLPHASE1120 participantsNkarta, Inc.

View Study Details

NCT05201469Recruiting

VIBRANT: VIB4920 for Active Lupus Nephritis

This is a multi-center double-blind placebo controlled clinical trial evaluating the efficacy of VIB4920 combined with mycophenolate mofetil (MMF) and prednisone in achieving a renal response in parti...

Miami, FLPHASE274 participantsNational Institute of Allergy and Infectious Diseases (NIAID)

View Study Details

NCT07570862Recruiting

A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis

The primary objective of this trial is to evaluate the efficacy and safety of FT819, comprised of allogeneic T cells that express a CD19-targeted CAR, following bendamustine administration in particip...

Miami, FLPHASE253 participantsFate Therapeutics

View Study Details

About Lupus Nephritis Clinical Trials in Miami

Lupus nephritis is kidney inflammation caused by systemic lupus erythematosus, occurring in up to 60% of SLE patients. It can lead to kidney failure if untreated. Treatment includes immunosuppressive medications such as mycophenolate, cyclophosphamide, and newer agents like voclosporin.

There are currently 5 lupus nephritis clinical trials recruiting participants in Miami, FL. These studies are seeking a combined 1,439 participants. Research is being sponsored by Massachusetts General Hospital, VA Office of Research and Development, Nkarta, Inc. and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Lupus Nephritis Clinical Trials in Miami — FAQ

Are there lupus nephritis clinical trials in Miami?

Yes, there are 5 lupus nephritis clinical trials currently recruiting in Miami, FL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Miami?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Miami research site will contact you about next steps.

Are clinical trials in Miami free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Miami studies also compensate for your time and travel.

What lupus nephritis treatments are being tested?

The 5 active trials in Miami are testing new therapies including novel drugs, biologics, and treatment approaches for lupus nephritis.

Data updated October 17, 2026 from ClinicalTrials.gov